You have 9 free searches left this month | for more free features.

PLK Inhibitor

Showing 1 - 25 of 7,368

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Pittsburgh (Onvansertib)

Recruiting
  • Small-cell Lung Cancer
  • Small Cell Lung Carcinoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 29, 2022

Recurrent Chronic Myelomonocytic Leukemia, Refractory Chronic Myelomonocytic Leukemia Trial in Rochester (Biospecimen

Recruiting
  • Recurrent Chronic Myelomonocytic Leukemia
  • Refractory Chronic Myelomonocytic Leukemia
  • Biospecimen Collection
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +11 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Mar 22, 2022

Solid Tumor, Adult Lymphoma Trial in Duarte, Houston (CYC140)

Recruiting
  • Solid Tumor, Adult Lymphoma
  • Duarte, California
  • +4 more
Oct 18, 2022

Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Phoenix, Arizona
  • +5 more
Dec 15, 2022

Metastatic Colorectal Cancer, KRAS Gene Mutation Trial in United States (Onvansertib, Bevacizumab, FOLFIRI)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • KRAS Gene Mutation
  • Phoenix, Arizona
  • +6 more
Nov 10, 2022

Prostate Cancer Trial in Canada (Adavosertib, Savolitinib, Darolutamide)

Recruiting
  • Prostate Cancer
  • Edmonton, Alberta, Canada
  • +10 more
May 9, 2022

Advanced Solid Tumor Trial in Bronx, Portland, Dallas (BAL0891, Carboplatin, Paclitaxel)

Recruiting
  • Advanced Solid Tumor
  • Bronx, New York
  • +2 more
Mar 19, 2023

Sarcoma,Soft Tissue Trial in Spain (Selinexor 20 MG, Gemcitabine)

Recruiting
  • Sarcoma,Soft Tissue
  • Tenerife, Canarias, Spain
  • +10 more
Oct 27, 2023

Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Peripheral T Cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing/China, China
  • +1 more
Oct 9, 2023

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

Not yet recruiting
  • Cervical Cancer
  • Anti-PD-1 antibody balstilimab
  • Amsterdam, Netherlands
    Amsterdam UMC
Oct 17, 2023

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

Not yet recruiting
  • HIV Infections
  • Las Vegas, Nevada
  • +1 more
Aug 21, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023

Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Pavia, Lombardia, Italy
    Istituti Clinici Scientifici Maugeri
May 5, 2023

Blood Vessel Function in Postmenopausal Women With Breast Cancer

Active, not recruiting
  • Breast Cancer
  • Rochester, Minnesota
    Mayo Clinic
Jan 17, 2023

Chronic Kidney Disease Trial (Part A - Lorundrostat QD + Dapaglifozin QD, Part A - Lorundrostat QD, Part B - Lorundrostat QD

Not yet recruiting
  • Chronic Kidney Disease
  • Part A - Lorundrostat QD + Dapaglifozin QD
  • +2 more
  • (no location specified)
Nov 27, 2023

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2023

Healthy Trial in Biberach (BI 1810631, Itraconazole)

Recruiting
  • Healthy
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Apr 27, 2023

Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Birmingham, Alabama
  • +2 more
Jan 3, 2023

Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor Trial in Hangzhou (Tegoprazan, Esomeprazole)

Active, not recruiting
  • Vonoprazan
  • +2 more
  • Hangzhou, Zhejiang, China
    Hangzhou first people's Hospital
Dec 2, 2022

Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Worldwide (Ravulizumab)

Active, not recruiting
  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Ravulizumab
  • Aurora, Colorado
  • +19 more
Nov 16, 2022

Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor Trial in Hangzhou (Vonoprazan Tablets, Amoxicillin Capsules,

Recruiting
  • Vonoprazan
  • +2 more
  • Vonoprazan Tablets
  • +2 more
  • Hangzhou, Zhejiang, China
    Hangzhou first people's Hospital
Nov 23, 2022